Scabies in 2012;La gale en 2012

Revue Medicale Suisse

Volumn 8, Issue 335, 2012, Pages 718-725

  Gaspard, L ^a   Laffitte, E ^b   Michaud, M ^b   Eicher, N ^b   Lacour, O ^c   Toutous Trellu, L ^b  

^a SERVICE DE MÉDECINE DE PREMIER RECOURS   (Switzerland)

^b Service de Dermatologie   (Switzerland)

^c Service du Médecin Cantonal   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; PERMETHRIN; ANTIPARASITIC AGENT;

BED; CLEANING; CLINICAL EXAMINATION; CLOTHING; DISEASE TRANSMISSION; HEALTH INSURANCE; HUMAN; MICROBIOLOGICAL EXAMINATION; REIMBURSEMENT; REVIEW; SCABIES; SOCIAL CLASS; SWITZERLAND; ANIMAL; ARTICLE;

ANIMALS; ANTIPARASITIC AGENTS; HUMANS; IVERMECTIN; PERMETHRIN; SCABIES;

EID: 84861674839     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Chosidow O. Scabies. N Engl J Med 2006;354:1718-27.
2. www.invs.sante.fr/publications/2008/epidemie-gale-commmunautaire/ epidemie-gale-commmunautaire.pdf
3. Scabies fact sheet. Atlanta: Center of disease control and prevention 2005. Accessed march 24, 2006, at www.cdc.gov/ncidod/parasites/scabies/facsht- scabies.htm
4. www.who.int/water-sanitation-health/diseases/scabies/fr
5. CClin Sud-ouest. Recommandations concernant la gestion de la gale dans les établissements de soins et médico-sociaux, 2004.
6. Legoux A, Doutre MS, Noblesse I, Beylot-Barry M, Beylot C. Contagiosité et traitement de la gale en 2002. Nouv Dermatol 2002;21:496-8.
7. Sparsa A, Bonnetblanc JM, Peyot I, et al. Effets secondaires de l'ivermectine utilisée dans le traitement de la gale. Ann Dermatol Venereol 2006;133:784-7. (Pubitemid 44579374)
8. Pasay C, Wlaton S, Fisher K, Holt D, McCarthy J. PCR-based assay to survey knockdown resistance to pyrethroid acaricid in human scabies mites (Sarcoptes scabiei var hominis). Am J Trop Med Hyg 2006;74:649-57. (Pubitemid 46774449)
9. Haas N, Lindemann U, Frank K, et al. Rapid and preferential sebum secretion of ivermectine: A new factor that may determinate drug reponsiveness in patients with scabies. Arch Dermatol 2002;138:1618-9.
10. Avis du Conseil supérieur d'hygiène publique de France - Section maladies transmissible - du 27 Juin 2003, relatif à la conduite à tenir devant un cas de gale.
11. Coyne PE, Addiss DG. Death associated with ivermectin for scabies. Lancet 1997;350:215-6.
12. Worowski KA DEC. STD Treatment Guidelines 2010;90.
13. Sharma R, Singal A. Topical permethrin and oral ivermectin in the management of scabies: A prospective, randomized, double blind, controlled study. Indian J Dermatol Venereol Leprol 2011;77:581-6.